| NCT06888921 | A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer | RECRUITING | PHASE1, PHASE2 | 2025-07-21 | 2027-03 | 2027-03 |
| NCT06759649 | A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies | RECRUITING | PHASE1 | 2025-01-07 | 2027-11-22 | 2027-11-22 |
| NCT04570839 | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. | COMPLETED | PHASE1, PHASE2 | 2020-08-31 | 2024-05-15 | 2024-05-15 |
| NCT04354246 | COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies | ACTIVE_NOT_RECRUITING | PHASE1 | 2020-03-31 | 2025-12-30 | 2025-12-30 |
| NCT03667716 | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. | COMPLETED | PHASE1 | 2018-09-06 | 2024-01-30 | 2024-01-30 |